GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E
F. Gao et al., GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E, AIDS research and human retroviruses, 10(11), 1994, pp. 1359-1368
As part of the WHO Network for HIV Isolation and Characterization, we
PCR amplified, cloned, and sequenced gp120 and gp160 genes from 12 HIV
-1 isolates collected in four WHO-sponsored vaccine evaluation sites (
Brazil, Rwanda, Thailand, Uganda). Envelope clones were derived from P
BMC-grown isolates obtained from asymptomatic individuals within 2 yea
rs of seroconversion. Analysis of their deduced amino acid sequences i
dentified all but one to contain an uninterrupted open reading frame.
Transient expression and biological characterization of selected gp160
constructs identified six clones to encode full length and functional
envelope glycoproteins. Phylogenetic analysis of their nucleotide seq
uences revealed that they represent HIV-1 subtypes A, B, C, and E. Sin
ce current knowledge of HIV-1 envelope immunobiology is almost exclusi
vely derived from subtype B viruses, these reagents should facilitate
future envelope structure, function and antigenicity studies on a broa
der spectrum of viruses. This should assist in the design and evaluati
on of effective vaccines against HIV-1.